AR058572A1 - 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona - Google Patents
3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-onaInfo
- Publication number
- AR058572A1 AR058572A1 ARP060105634A ARP060105634A AR058572A1 AR 058572 A1 AR058572 A1 AR 058572A1 AR P060105634 A ARP060105634 A AR P060105634A AR P060105634 A ARP060105634 A AR P060105634A AR 058572 A1 AR058572 A1 AR 058572A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- group
- phenylmethyl
- piperidinyl
- nitro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Reivindicacion 1: Procedimiento para preparar el compuesto de la formula (1) caracterizado porque (a) se hace reaccionar ácido 2-nitrofenilacético con 4-amino-N-fenilmetilpiperidina en 2-nitro-N-[1-fenilmetil)-4-piperidinil]-fenilacetamida de la formula (2); (b) se hidrogena el grupo nitro de la 2-nitro-N-[1-(fenilmetil)-4-piperidinil]-fenilacetamida obtenida de la formula 2 en el grupo amino, con lo cual se produce el compuesto de la formula (3); (c) se hace reaccionar el producto intermediario de la formula 3 por adicion de un éster y en presencia de una base en un carbamato de la formula general (4) en donde R1 es un grupo fenilo, bencilo, alilo, 2,2,2-tricloroetilo o un grupo alquilo C1-6 lineal o ramificado, y (d) se disuelve el compuesto obtenido de la formula general 4 en un disolvente orgánico aprotico, se convierte el grupo carbonilo por adicion de un agente de reduccion en un grupo metileno y se cicla en 3-[1-(fenilmetil)-4-piperidinil]-2,3,4,5-tetrahidro- 1,3-benzodiazepin-2(1H)-ona de la formula (5).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05028476 | 2005-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058572A1 true AR058572A1 (es) | 2008-02-13 |
Family
ID=36340767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105634A AR058572A1 (es) | 2005-12-24 | 2006-12-20 | 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona |
Country Status (15)
Country | Link |
---|---|
US (1) | US7473778B2 (es) |
EP (1) | EP1968952B1 (es) |
JP (1) | JP4917613B2 (es) |
KR (1) | KR20080090464A (es) |
CN (1) | CN101304980B (es) |
AR (1) | AR058572A1 (es) |
AT (1) | ATE519750T1 (es) |
AU (1) | AU2006331404A1 (es) |
BR (1) | BRPI0620621A2 (es) |
CA (1) | CA2633932A1 (es) |
IL (1) | IL192316A0 (es) |
RU (1) | RU2008130259A (es) |
TW (1) | TW200732319A (es) |
WO (1) | WO2007074130A2 (es) |
ZA (1) | ZA200802671B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012171987A1 (en) * | 2011-06-16 | 2012-12-20 | Lonza Ltd | A process for extraction of peptides and its application in liquid phase peptide synthesis |
GB201707938D0 (en) | 2017-05-17 | 2017-06-28 | Univ Sheffield | Compounds |
WO2021218863A1 (zh) * | 2020-04-26 | 2021-11-04 | 江苏恩华药业股份有限公司 | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3474090A (en) | 1966-12-22 | 1969-10-21 | American Cyanamid Co | 3-aminoalkyl-1,3-benzodiazepin-2-ones |
AU4698399A (en) * | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
DE19911039A1 (de) | 1999-03-12 | 2000-09-14 | Boehringer Ingelheim Pharma | Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US7220862B2 (en) | 2002-06-05 | 2007-05-22 | Bristol-Myers Squibb Company | Calcitonin gene related peptide receptor antagonists |
EP1689493A4 (en) | 2003-12-05 | 2008-04-23 | Bristol Myers Squibb Co | ANTAGONISTS OF THE CALCITONIN GENE RELATED PEPTIDE RECEPTOR |
EP1619187A1 (de) | 2004-07-23 | 2006-01-25 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung von 3-(4-Piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on |
-
2006
- 2006-12-06 US US11/567,429 patent/US7473778B2/en active Active
- 2006-12-20 AR ARP060105634A patent/AR058572A1/es unknown
- 2006-12-21 CN CN2006800422666A patent/CN101304980B/zh not_active Expired - Fee Related
- 2006-12-21 KR KR1020087018281A patent/KR20080090464A/ko not_active Application Discontinuation
- 2006-12-21 JP JP2008546464A patent/JP4917613B2/ja not_active Expired - Fee Related
- 2006-12-21 WO PCT/EP2006/070067 patent/WO2007074130A2/de active Application Filing
- 2006-12-21 BR BRPI0620621-2A patent/BRPI0620621A2/pt not_active IP Right Cessation
- 2006-12-21 CA CA002633932A patent/CA2633932A1/en not_active Abandoned
- 2006-12-21 EP EP06847036A patent/EP1968952B1/de not_active Not-in-force
- 2006-12-21 RU RU2008130259/04A patent/RU2008130259A/ru not_active Application Discontinuation
- 2006-12-21 AT AT06847036T patent/ATE519750T1/de active
- 2006-12-21 AU AU2006331404A patent/AU2006331404A1/en not_active Abandoned
- 2006-12-22 TW TW095148581A patent/TW200732319A/zh unknown
-
2008
- 2008-03-26 ZA ZA200802671A patent/ZA200802671B/xx unknown
- 2008-06-19 IL IL192316A patent/IL192316A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1968952B1 (de) | 2011-08-10 |
KR20080090464A (ko) | 2008-10-08 |
CN101304980B (zh) | 2011-05-11 |
WO2007074130A2 (de) | 2007-07-05 |
BRPI0620621A2 (pt) | 2011-11-16 |
AU2006331404A1 (en) | 2007-07-05 |
WO2007074130A3 (de) | 2007-08-16 |
IL192316A0 (en) | 2009-02-11 |
CN101304980A (zh) | 2008-11-12 |
ATE519750T1 (de) | 2011-08-15 |
RU2008130259A (ru) | 2010-01-27 |
JP2009521420A (ja) | 2009-06-04 |
US20080009617A1 (en) | 2008-01-10 |
EP1968952A2 (de) | 2008-09-17 |
CA2633932A1 (en) | 2007-07-05 |
ZA200802671B (en) | 2009-01-28 |
JP4917613B2 (ja) | 2012-04-18 |
US7473778B2 (en) | 2009-01-06 |
TW200732319A (en) | 2007-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR094588A2 (es) | Proceso de obtención de un compuesto derivado de benzimidazol y composición farmacéutica | |
GT200600356A (es) | Mezclas fungicidas que contienen anilidas sustituidas de acido 1-metilpirazol-4-ilcarboxilico. | |
ATE549927T1 (de) | Fungizide zusammensetzung, die ein saures amidderivat enthält | |
MA31176B1 (fr) | Derives spirocycliques de l'acide tetronique | |
CL2012001171A1 (es) | Procedimiento para la preparacion del ester n-[[2-[[[4-[[[(hexiloxicarbonil)]4-amino]iminometil]fenil]amino]metil]1-alquil-1h-benzimidazol-5-il]carbonil]n-2-piridinil-etilico de beta-alanina; y uno de los compuestos intermediarios considerados. | |
CY1112402T1 (el) | Ενισχυτες υποδοχεων γλουταμικου | |
EA201100877A1 (ru) | Спирогетероциклические n-оксиамиды в качестве пестицидов | |
DE602006010132D1 (de) | Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol | |
CR9113A (es) | Compuestos acetamida como fungicidas | |
DE602005010804D1 (de) | Herstellung von Metallverbindungen der 12. und 13. Gruppe, die niedrige Mengen an Sauerstoff-enthaltenden Verunreinigungen aufweisen | |
NZ595942A (en) | Processes for the preparation of rivaroxaban and intermediates thereof | |
AR049540A1 (es) | Derivados de quinazolindiona como inhibidores del parp; metodos para su preparacion; composiciones farmaceuticas que los contienen como ingrediente activo y su uso en medicamentos para el tratamiento o prevencion del cancer. | |
EP1914231A3 (de) | 2-Methyl-2-alkenyl-substituierte 1,3-Dioxane als Riechstoffe | |
ECSP066802A (es) | Nuevas amidas de ácidos carboxílicos como inhibidores del factor xa | |
UA94910C2 (ru) | Замещенные глицинамиды с антитромбическим действием и ингибирующим действием на фактор ха | |
NO20071476L (no) | Antidiuretiske midler. | |
AR073932A1 (es) | Compuestos de esteres de acido 2-(aminometiliden)-4,4-difluoro-3- oxobutirico y procedimiento para su preparacion | |
UY30533A1 (es) | Acetamidas n-{1-[4(1-ciano-1-metil)fenil]etil}sustituidas derivadas del acido 2-(1h-bencimidazol-1il) acético | |
AR035531A1 (es) | Composicion para el control de plagas endoparasiticas en ganados y animales domesticos, un metodo para su control y el uso de dicha composicion para la preparacion de medicamentos | |
AR058572A1 (es) | 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodiazepin-2(1h)-ona | |
EA200802388A1 (ru) | Способ получения солифенацина | |
DK1794202T3 (da) | Stabiliseret tværbindende sammensætning | |
TW200714596A (en) | Isotopically substituted proton pump inhibitors | |
NO20065789L (no) | Cinnamidforbindelse | |
MX2008000011A (es) | Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |